Filter Results:
(10)
Show Results For
- All HBS Web (31)
- Faculty Publications (7)
Show Results For
- All HBS Web (31)
- Faculty Publications (7)
Page 1 of 10
Results
Sort by
- 27 Sep 2015
- News
Pharma gives drug development the Hollywood treatment
- 07 Feb 2024
- News
The Sound of Success
A groundbreaking gene therapy developed by Akouos, Inc., a precision genetic medicine company founded in 2016 by Emmanuel (Manny) Simons (MBA 2012), has enabled an 11-year-old boy from Morocco to hear sounds for the first time. According to a recent New York Times... View Details
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
prices and expand access to life-saving therapies,” she says. After college, Rabah joined the biotech company Sio Gene Therapies, where she had the opportunity to speak with parents of children with Tay-Sachs disease, an ultra-rare... View Details
- 01 Jun 2023
- News
From Big Pharma to Startup
Hunter Goble (MBA 2022) did not enroll in Harvard Business School with dreams of becoming an entrepreneur. After earning his MBA, Goble intended to return to Eli Lilly to continue to work building brands and launching products. He envisioned himself leading a big,... View Details
Keywords: April White
- 01 Dec 2013
- News
Innovation as Antidote
inspiration typically comes from a very human place. DART Therapeutics CEO Gene Williams (MBA 1987) ("Your Own Medicine"), for instance, told us about a revelation he had during a 2002 trip to Rotterdam to observe clinical trials for the... View Details
Keywords: Health, Social Assistance
- 06 Dec 2021
- News
Vision: Sound Science
as sound. Getting a healthy copy of the critical gene to the appropriate cells is a solution, but precision inner-ear drug delivery has been a historical stumbling block. An early breakthrough for us was figuring out a way to pair View Details
Keywords: Deb Blagg
- 01 Dec 2013
- News
Your Own Medicine
compounds owned by struggling biotechs. Williams usually calls Tracy once or twice a day, with about a dozen emails back and forth daily. Things are moving. Long term, the Secklers see stem cell or gene replacement View Details
- 03 Mar 2017
- News
Big Blue’s Big Bet
myeloid leukemia, a blood cancer in which abnormal white blood cells grow quickly. They comforted her by saying that the chemotherapy they were prescribing would attack the abnormal cells. And it did. But her recovery from post-remission View Details
Keywords: Paul Kix; illustrations by Dan Page